Therapeutic efficacy of an alpha-particle emitter labeled anti-GD2 humanized antibody against osteosarcoma-a proof of concept study.

Published in: European journal of nuclear medicine and molecular imaging (2023)

This study highlights the potential of hu3F8-based alpha-particle therapy as a promising treatment strategy for OS.

Keyphrases